arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

MBX Biosciences, Inc.

MBX Health Care Biotechnology: Pharmaceutical Preparations
$30.28
▼ -2.0% Today
as of Jun 7, 07:20 ET
Last 30 days +4.27% Apr 28 → Jun 05
$27.62 $31.20 $34.79 $38.37 $41.95 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$30.59
High
$30.65
Low
$29.41
Volume
$570,327
Avg Vol
$775,225
Mkt Cap
$1.5B
P/E (TTM)
Beta
52w High
$45.85
52w Low
$9.43
Div Yield
Shares Out
$48M

Overview

52-week range
$9.43
$46
57% of range
Avg surprise (last 2)
+15.0%
Avg reaction (last 2)
+4.2%
100% positive
Latest IV / EM
153%
EM ±21.1% · $30 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-12.62$-9.59$-6.56$-3.54$-0.51 Actual $-9.40Actual $-10.26Actual $-12.62Actual $-2.78Actual $-0.71Est $-0.81Actual $-0.58Actual $-0.63Actual $-0.51Est $-0.62 SepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-24M$-22M$-20M$-18M$-17M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.51 $-0.62 +17.7% +28.2% +8.1% earnings
Tue Sep 30, 2025Sep 2025 $-0.63 financials
Mon Jun 30, 2025Jun 2025 $-0.58 financials
Mon May 12, 2025Mar/2025 $-0.71 $-0.81 +12.3% +0.3% earnings
Mon Sep 30, 2024Sep 2024 $-2.78 financials
Sun Jun 30, 2024Jun 2024 $-12.62 financials
Sun Mar 31, 2024Mar 2024 $-10.26 financials
Sat Sep 30, 2023Sep 2023 $-9.40 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-27M$-24M$-22M$-27M$-20M$-17M
Net income$-24M$-22M$-19M$-24M$-18M$-16M
EPS (diluted)$-0.50$-0.63$-0.58$-0.71$-2.78$-12.62

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$45M$75M$223M$40M$30M$49M$133M
Inventory
Total current assets$449M$382M$398M$229M$244M$267M$281M
Total assets$453M$385M$400M$232M$246M$269M$282M
Long-term debt
Total liabilities$15M$16M$13M$12M$11M$11M$11M
Total equity$438M$369M$388M$219M$235M$257M$271M$-98M

Implied volatility — last 90 days

147%150%152%155%157% Jun 07 — IV 153% · EM ±21.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.